Hematology Home >
- Faculty
Stephen J. Schuster, M.D.Associate Professor of Medicine at the Hospital of the University of Pennsylvania
Attending Physician, Department of Medicine, Division of Hematology-Oncology
Director, Lymphoma Program
Director, Lymphoma Translational Research
Department: Medicine
Contact information
Perelman Center for Advanced Medicine
2 West Pavilion, Room 2-393S 3400 Civic Center Blvd Philadelphia, PA 19104
Office: (215) 614-1846
Fax: (215) 662-4064 Email: schustes@mail.med.upenn.edu
Education:
B.S. (Psychology) Saint Joseph's University, Philadelphia, PA, 1976. Laboratory Research Technician, Division of Rheumatology, Hahnemann Medical College and Hospital, Philadelphia, PA, 1977. M.D. Jefferson Medical College, Philadelphia, PA, 1981.
Post-Graduate Training
Medical Internship, Pennsylvania Hospital, Philadelphia, PA., 1981-1982. Resident in Medicine, Pennsylvania Hospital, Philadelphia, PA, 1982-1984. Cardeza Clinical and Research Fellow in Medicine (Hematology), Jefferson Medical College, Philadelphia, PA, 1984-1988. Postdoctoral Research Fellowship (NIH Sponsored Individual NRSA), Cardeza Foundation for Hematologic Research, Jefferson Medical College, Philadelphia, PA, 1986-1988. Medical Oncology Fellowship, Pennsylvania Hospital, Philadelphia, PA, 1988-1989.
Certifications
Permanent linkDiplomate, National Board of Medical Examiners, 1982. Diplomate, American Board of Internal Medicine, 1984. Diplomate, American Board of Hematology, 1986. Diplomate, American Board of Medical Oncology, 1989. Selected PublicationsShrikanthan, S., Kim, H., Elstrom, R., Kumar, R., Schuster, S.J., Zhuang, H.M., Alavi, A. : FDG-PET imaging of lymphoma: importance of WHO classification. The Society of Nuclear Medicine 51th Annual Meeting. Journal of Nuclear Medicine 45(5S): 93P, 2004.Shrikanthan, S., Zhuang, H.M., Schuster, S.J., Alavi, A. : FDG-PET imaging in diagnosis of mantle cell lymphoma. The Society of Nuclear Medicine 51th Annual Meeting. Journal of Nuclear Medicine 45(5S): 93P, 2004. Kumar, R., Bozkurt, M.F., Maillard, I., Shrikanthan, S., Zhuang, H.M., Newberg, A., Schuster, S.J., Xiu, Y., Alavi, A. : Positive FDG-PET scans after a few cycles of chemotherapy is predictive of poor prognosis in patients with aggressive lymphoma and Hodgkin’s disease. The Society of Nuclear Medicine 51th Annual Meeting. Journal of Nuclear Medicine 45(5S): 316P, 2004. Kumar, R., Bozkurt, M.F., Maillard, I., Srikanthan, S., Zhuang, H.M., Newberg, A., Schuster, S.J., Alavi, A. : Comparison of whole-body F18-FDG-PET and CT scans for restaging malignant lymphoma. The Society of Nuclear Medicine 51th Annual Meeting. Journal of Nuclear Medicine 45S(5S): 317P, 2004. Bozkurt, M.F., Kumar, R., Maillard, I., Shrikanthan, S., Bural, G., Wintering, N., Schuster, S.J., Elstrom, R., Zhuang, H.M., Alavi, A. : Lesion by lesion, region by region, and patient by patient comparison of FDG-PET and CT/MRI findings in Hodgkin’s disease and non-Hodgkin’s lymphoma. The Society of Nuclear Medicine 51th Annual Meeting. Journal of Nuclear Medicine 45(5S): 317P, 2004.
|
